Janus Henderson Group plc (NYSE:JHG ) Q3 2024 Results Conference Call October 31, 2024 9:00 AM ET Company Participants Ali Dibadj - Chief Executive Officer Roger Thompson - Chief Financial Officer Conference Call Participants Ken Worthington - JPMorgan Dan Fannon - Jefferies Patrick Davitt - Autonomous Research Bill Katz - TD Cowen Craig Siegenthaler - Bank of America Mike Brown - Wells Fargo J...
LONDON--(BUSINESS WIRE)--Janus Henderson Group plc (NYSE: JHG; “JHG," "Janus Henderson,” or the “Company”) published its third quarter 2024 results for the period ended September 30, 2024. Third quarter 2024 operating income was US$164.7 million compared to US$164.3 million in the second quarter 2024 and US$121.7 million in the third quarter 2023. Adjusted operating income, adjusted for one-tim...
DENVER , Oct. 7, 2024 /PRNewswire/ -- Global active asset manager, Janus Henderson (NYSE: JHG), today released its "Risky Business? What Makes You Invest (or Not)," report (the "Report"), which seeks to better understand investment habits amongst Americans.
LONDON--(BUSINESS WIRE)--Janus Henderson Group plc (NYSE: JHG) will announce its third quarter 2024 results on Thursday, October 31, 2024, at 7:30 a.m. ET. A conference call and webcast to discuss the results will be held at 9:00 a.m. ET. Those wishing to participate in the conference call should call the applicable number below and reference the Janus Henderson Results Briefing (Conference ID:...
On September 30, 2024, Janus Henderson Group PLC, a prominent investment firm, significantly increased its stake in Soleno Therapeutics Inc (SLNO, Financial) by acquiring an additional 804,805 shares. This transaction, executed at a price of $50.49 per share, has raised the firm's total holdings in Soleno to 4,163,678 shares.
The Fund returned 1.87% and the J.P. Morgan CLO AAA Index returned 1.77%. The Fund's slightly longer duration contributed: a small allocation to AA rated collateralized loan obligations (CLOs) and security selection within AAA rated CLOs further contributed. In our view, floating-rate CLOs should continue to benefit from a healthy economy that underpins a less-aggressive rate cutting cycle, kee...
I am positive on Janus Henderson's recent capital allocation actions pertaining to acquisitions and capital return. Janus Henderson's performance has improved significantly in Q2 2024, considering its revenue and earnings growth acceleration that surpassed expectations and a return to positive fund inflows. I have changed my rating for JHG stock from a Hold to a Buy after identifying favorable ...
Register for Free
StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.